2004 Access Cultivation Patients 
The Cannigma
OCTOBER 20, 2021
In 2020, Prohibition Partners stated that there are currently an estimated 3,000 patients receiving medical cannabis treatment in Switzerland. But these numbers arguably run counter to the results of a 2008 vote , in which 63% of Swiss voters rejected a referendum to legalize the possession, sale, and cultivation of cannabis.
Cannabis Law Report
JULY 2, 2022
Though it joined the European Union in 2004, Lithuania remained for several years the only country in the EU that criminalized even the cultivation of hemp – the non-psychoactive variety of the plant. It was only in 2013 that the country aligned its policy with the rest of the Union and allowed the cultivation of hemp by local farmers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
AUGUST 16, 2021
Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access. At the time, it was considered to be one of the largest cannabis operations of its time, serving up to 1,000 medical cannabis patients.
Canna Care Docs
NOVEMBER 23, 2020
Across these states, in different parts of the US, the message was clear: people recognize the benefits of legalization and want access to cannabis in their communities. Initiative 65 (74%) passed over the Alternative 65A (32%)—the latter of which would have restricted medicinal cannabis to terminally ill patients.
Cannabis Law Report
AUGUST 6, 2019
patients in a non-medical marijuana use state from purchasing or using cannabis medication obtained in the neighboring medical marijuana “border state.” public school districts conducted random drug testing in at least one of their high schools during the 2004–2005 school year (Ringwalt et al. ” .
The Cannigma
OCTOBER 10, 2021
The following year, Greek lawmakers approved a law to allow the cultivation and processing of medical cannabis with up to 0.2% tetrahydrocannabinol (THC), which was followed in 2021 by the approval of a bill to legalize the cultivation and sale of medical marijuana with more than 0.2% A survey carried out in 2004 found that 8.6%
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. Refractory paediatric epilepsy.
Expert insights. Personalized for you.
52 
Let's personalize your content